Cargando…

A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4(+) and CD8(+) T-Cell Response against Mycobacterium tuberculosis Immunogens

Mycobacterium tuberculosis infection is still a major global public health problem. Presently the only tuberculosis (TB) vaccine available is Bacille Calmette-Guérin (BCG), although it fails to adequately protect against pulmonary TB in adults. To solve this problem, the development of a new effecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Miao, Xia, Zhi Yang, Bao, Lang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987877/ https://www.ncbi.nlm.nih.gov/pubmed/24741595 http://dx.doi.org/10.1155/2014/395626

Ejemplares similares

Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells
por: Chapman, Rosamund, et al.
Publicado: (2012)

Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
por: Reyes, Fátima, et al.
Publicado: (2013)

Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice
por: DÜZENLİ, Özgün Fırat, et al.
Publicado: (2021)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis
por: DiChiara, Jeanne M., et al.
Publicado: (2010)

Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection
por: Xu, Zheng Zhong, et al.
Publicado: (2016)

Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG
por: Taniguchi, Keiichi, et al.
Publicado: (2013)

Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T cell dependent manner
por: Moliva, Juan I., et al.
Publicado: (2017)

Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006)

Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022)

Enhanced immunogenicity of Mycobacterium bovis BCG through CRISPRi mediated depletion of AftC
por: Madduri, Bala T.S.A., et al.
Publicado: (2022)

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis
por: Chesson, Charles B., et al.
Publicado: (2018)

Photochemically-Mediated Inflammation and Cross-Presentation of Mycobacterium bovis BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice
por: Waeckerle-Men, Ying, et al.
Publicado: (2022)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
por: Vidal, Enric, et al.
Publicado: (2017)

Biochemical characterization of the maltokinase from Mycobacterium bovis BCG
por: Mendes, Vítor, et al.
Publicado: (2010)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
por: Chiu, Nan-Chang, et al.
Publicado: (2015)

Optimisation of Mycobacterium bovis BCG Fermentation and Storage Survival
por: Pascoe, Jordan, et al.
Publicado: (2020)

Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosis
por: Moliva, Juan I., et al.
Publicado: (2019)

Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice
por: Cha, Seung Bin, et al.
Publicado: (2015)

Genomic and proteomic analyses of Mycobacterium bovis BCG Mexico 1931 reveal a diverse immunogenic repertoire against tuberculosis infection
por: Orduña, Patricia, et al.
Publicado: (2011)

Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis
por: Tirado, Yanely, et al.
Publicado: (2015)

Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep
por: Balseiro, Ana, et al.
Publicado: (2017)

CD8(+) Regulatory T Cells, and Not CD4(+) T Cells, Dominate Suppressive Phenotype and Function after In Vitro Live Mycobacterium bovis-BCG Activation of Human Cells
por: Boer, Mardi C., et al.
Publicado: (2014)

Whole-Genome Sequence of Mycobacterium bovis BCG-1 (Russia)
por: Ludannyy, R., et al.
Publicado: (2015)

Phosphate starvation enhances phagocytosis of Mycobacterium bovis/BCG by macrophages
por: Espinosa-Cueto, Patricia, et al.
Publicado: (2020)

BCG vaccine: Disseminated Mycobacterium bovis infection: case report
Publicado: (2021)

Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
por: Lee, Mi-Hyun, et al.
Publicado: (2023)

Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection
por: Wu, Yaqi, et al.
Publicado: (2018)

Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis
por: Hildebrand, Rachel E., et al.
Publicado: (2022)

Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant
por: Keller, Peter M, et al.
Publicado: (2008)

Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress
por: Gallant, James L., et al.
Publicado: (2016)

Identification of four novel DC-SIGN ligands on Mycobacterium bovis BCG
por: Carroll, Maria V., et al.
Publicado: (2010)

Complete Genome Sequence of Mycobacterium bovis Strain BCG-1 (Russia)
por: Sotnikova, Evgeniya A., et al.
Publicado: (2016)

Detailed Structural Analysis of the Immunoregulatory Polysaccharides from the Mycobacterium Bovis BCG
por: Luo, Lan, et al.
Publicado: (2022)

Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model
por: Damjanovic, Daniela, et al.
Publicado: (2015)

Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection
por: Guerrero, G. G., et al.
Publicado: (2015)

Pulmonary Tuberculosis and Mycobacterium bovis, Uganda
por: Byarugaba, Frederick, et al.
Publicado: (2009)

Mycobacterium bovis Pulmonary Tuberculosis, Algeria
por: Tazerart, Fatah, et al.
Publicado: (2021)

Improving the Immunogenicity of the Mycobacterium bovis BCG Vaccine by Non-Genetic Bacterial Surface Decoration Using the Avidin-Biotin System
por: Liao, Ting-Yu Angela, et al.
Publicado: (2015)

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
por: Loxton, André G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bv49577ttef55g4qfror9l2hr7